Gastric carcinoma and Colorectal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Non-bedridden patients aged >=18 and <=75 years, regardless of gender. 2. Patients with histologically confirmed gastric cancer (including adenocarcinoma of the gastroesophageal junction) or colorectal cancer. 3. Participants voluntarily enroll in this study, demonstrate good compliance, and are willing to cooperate with follow-up.
Exclusion criteria
Exclusion criteria: 1. History of other malignancies within the past 5 years, except for cured basal cell carcinoma of the skin or carcinoma in situ of the cervix. 2. Presence of uncontrolled systemic diseases, including active infections, uncontrolled hypertension, diabetes mellitus, unstable angina, congestive heart failure, myocardial infarction (within 1 year prior to treatment initiation), severe arrhythmias requiring medication, or hepatic, renal, and metabolic disorders. 3. Conditions such as dysphagia, complete or incomplete gastrointestinal obstruction, active gastrointestinal bleeding, or perforation. 4. Pregnant or lactating women. 5. Participants unwilling to comply with contraceptive requirements during the study period. 6. History of psychotropic drug abuse with inability to abstain, or patients with psychiatric disorders. 7. Known hypersensitivity to any chemotherapy agents that may be used in the study. 8. Patients deemed unsuitable for inclusion by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lymph node metastasis detection rate; | — |
Countries
China
Contacts
The Seventh Affiliated Hospital Sun Yat-sen University